Biohaven (BHVN) Non-Current Assets (2021 - 2026)

Biohaven (BHVN) reported Non-Current Assets of $80.8 million for Q1 2026, up 6.0% on a YoY basis from $76.2 million in Q1 2025, and down 2.84% sequentially from $83.1 million in Q4 2025.

Biohaven (BHVN) Non-Current Assets (2021 - 2026) Analysis & Trends

Biohaven (BHVN) has 6 years of Non-Current Assets data on file, last reported at $80.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 6.0% year-over-year to $80.8 million; the trailing twelve-month figure through Mar 2026 stood at $325.0 million (up 10.45% YoY), and the FY2025 full-year result was $83.1 million, up 8.46% from the prior year.
  • Non-Current Assets retreated to $80.8 million in Q1 2026, from $83.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $85.5 million in Q3 2025 to a low of $55.1 million in Q3 2022.
  • A 5-year average of $73.9 million and a median of $74.0 million in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets soared 58.38% in 2022 and slipped 5.75% in 2024, its largest moves.
  • Tracing BHVN's Non-Current Assets over 5 years: stood at $74.8 million in 2022, then slipped by 5.41% to $70.8 million in 2023, then climbed by 8.29% to $76.6 million in 2024, then increased by 8.46% to $83.1 million in 2025, then slipped by 2.84% to $80.8 million in 2026.
  • Business Quant data shows BHVN's Non-Current Assets at $80.8 million in Q1 2026, $83.1 million in Q4 2025, and $85.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Biohaven 2.16 Bn 1.81 Bn - 80.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 80.76 Mn
Dec 31, 2025 83.12 Mn
Sep 30, 2025 85.51 Mn
Jun 30, 2025 75.59 Mn
Mar 31, 2025 76.19 Mn
Dec 31, 2024 76.64 Mn
Sep 30, 2024 70.02 Mn
Jun 30, 2024 71.37 Mn
Mar 31, 2024 69.79 Mn
Dec 31, 2023 70.77 Mn
Sep 30, 2023 72.17 Mn
Jun 30, 2023 72.62 Mn
Mar 31, 2023 74.05 Mn
Dec 31, 2022 74.82 Mn
Sep 30, 2022 55.10 Mn
Dec 31, 2021 47.24 Mn